Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
11985
Description
Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence; ODM derived from: https://clinicaltrials.gov/show/NCT00609310
Link
https://clinicaltrials.gov/show/NCT00609310
Keywords
Versions (2)
- 8/30/15 8/30/15 -
- 11/24/15 11/24/15 - Julian Varghese
Uploaded on
August 30, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Colorectal Cancer NCT00609310
Eligibility Colorectal Cancer NCT00609310
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT00609310
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
time interval; chemotherapy; colorectal; resection; adjuvant; surgery; n stage; cancer
Item
patient who had a recent surgical resection of colorectal cancer with pathologically proven stage 2 or stage 3 (without adjuvant chemotherapy or after completion of adjuvant chemotherapy) according to uicc. the time interval for recruitment should be within 3-12 month after surgery.
boolean
C0009402 (UMLS CUI [1])
female
Item
male or female
boolean
C0079399 (UMLS CUI [1])
caucasian
Item
caucasian
boolean
C0007457 (UMLS CUI [1])
no code found
Item
50 to 75 years old
boolean
C0001779 (UMLS CUI [1])
no code found
Item
broca-index: between -20 and +25%
boolean
C0003550 (UMLS CUI [1])
written consent
Item
who are willing and capable to confirm written consent to enrolment after ample information has been provided
boolean
C0021430 (UMLS CUI [1])
medical condition; conditions; study
Item
who are in a stable condition that it can be expected that no changes in relevant medical conditions will occur during the study
boolean
C0348080 (UMLS CUI [1])
medical history; vital signs; examination; extensive; clinical
Item
subjects with any major relevant clinical abnormality (as based on extensive medical history, physi-cal examination, vital signs)
boolean
C1704258 (UMLS CUI [1])
active cancer
Item
subjects with active cancer
boolean
C0006826 (UMLS CUI [1])
laboratory
Item
subjects with any major clinically relevant laboratory abnormality.
boolean
C0022877 (UMLS CUI [1])
substance; last
Item
subjects who participated in another trial with any investigational substance within the last 4 weeks
boolean
C0008976 (UMLS CUI [1])
drug dependent; alcohol abuse; moderately; suspected; active; phase; study; from
Item
subjects who are known or suspected to be (social) drug dependent, incl. those drinking more than moderately and who are not willing to abstain from alcohol abuse during the active study phase
boolean
C0221628 (UMLS CUI [1])
investigation; diet
Item
subjects who adhere to a extreme diet or lifestyle that might interfere with the investigation
boolean
C0012155 (UMLS CUI [1])
suspected; study
Item
subjects who are known or suspected not to comply with the study directives and/or who are known or suspected not to be reliable or trustworthy
boolean
C0680927 (UMLS CUI [1])
informed consent; suspected; agree; part
Item
subjects who are known or suspected not to be capable of understanding and evaluating the in-formation that is given to them as part of the formal information policy (informed consent), in par-ticular regarding the risks and discomfort to which they would agree to be exposed
boolean
C0021430 (UMLS CUI [1])